PRMT2 and cancer: A meta-analysis across 21 cancer types, which had sufficient numbers of normal controls (n ≥ 3), revealed that the mRNA levels of most PRMTs, except for PRMT2/9, were significantly upregulated in tumor specimens compared with corresponding controls (Figure 2B and Figure S2B).